A Study to Evaluate the Effects of 3 Months Dosing With GW856553, as Assessed FDG-PET/CT Imaging

Clinical trial NCT00633022 · COMPLETED

Trial details

NCT number: NCT00633022
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Atherosclerosis

Start date: 2008-06-02
Primary completion: 2009-12-03
Enrollment: 99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.